Collaboration to take Cytovation’s synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinomaCancer Research UK’s Centre for Drug Development to run the trial at sites ...
Research has introduced daromun, therapeutic vaccines, and novel combinations for metastatic melanoma, reshaping the ...
NDAQ:ZLAB) Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell ...
One of the earliest proponents of evidence-based medicine, Professor David Sackett, wrote, “Good doctors use both individual ...
Previously, clinical research findings on cadonilimab in the treatment of various malignancies have been published in internationally renowned journals such as The Lancet, The Lancet Oncology, Nature ...
Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...
Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, ...
In an interview, Danielle Mitchell of BWICR discussed the importance of increasing diversity in clinical research and making ...
Stuart Therapeutics completed a Phase 3 trial for ST-100, a treatment for dry eye disease, involving a randomized, ...
GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...
A research team from the University of Minnesota Medical School recently received a three-year, $1.2 million grant from the National Institutes of Health to study the use of transcranial magnetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback